Portable Oxygen Concentrators Market Outlook: Respiratory Care Demand and Growth Opportunities

According to IMARC Group's latest research publication, The global portable oxygen concentrators market size was valued at USD 2.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 3.6 Billion by 2034, exhibiting a CAGR of 6.62% from 2026-2034.

How AI is Reshaping the Future of Portable Oxygen Concentrators Market

• Predictive Maintenance and Device Uptime: AI analyzes sensor data from POCs to flag potential hardware failures before they occur, cutting unplanned downtime and ensuring patients receive uninterrupted oxygen therapy at home or in clinical settings.
• Smart Oxygen Flow Optimization: Machine learning algorithms monitor real-time breathing patterns and automatically adjust oxygen delivery, reducing wastage by syncing flow with patient respiration cycles, extending battery life significantly.
• Remote Patient Monitoring and Alerts: AI-powered mobile connectivity platforms track usage data, oxygen saturation, and device performance remotely, enabling clinicians to intervene early and reduce hospital readmissions among chronic respiratory patients.

Explore Updated 2026 Market Trends & Analysis

Portable Oxygen Concentrators Industry Overview:

The rising global burden of respiratory diseases is the single biggest force behind this market's growth. WHO estimates put the number of people living with chronic respiratory conditions, including COPD, asthma, and pulmonary fibrosis, at around 545 million worldwide. Governments are responding: India's Rs 500 crore medical devices initiative, launched in November 2024, specifically targets local production of oxygen concentrators to reduce import dependency. North America currently holds over 38.9% market share, driven by Medicare reimbursement support and around 16 million Americans diagnosed with COPD alone.

Portable Oxygen Concentrators Market Trends and Drivers

The shift toward home-based respiratory care is fundamentally changing how patients manage chronic conditions. According to the European Respiratory Society, 60% of patients with chronic respiratory diseases prefer home care over hospital stays, citing comfort and convenience. This preference is fueling demand for POCs that are compact, battery-efficient, and easy to operate without clinical supervision. Inogen's June 2024 study, drawing on data from 244,000 patients, confirmed that POCs improve survival rates and deliver better cost-effectiveness compared to traditional oxygen therapy, reinforcing the clinical and financial case for home adoption.

Technological innovation is rapidly raising the performance bar across the segment. Inogen's October 2024 launch of the Rove 4 POC, delivering 840ml/min of oxygen with up to 5.75 hours of operation in a sub-3-pound design, is a strong example of where product development is heading. Pulse flow technology now accounts for 69.5% of the market, valued for its lightweight form factor and synchronized oxygen delivery that reduces waste. Meanwhile, Belluscura secured a USD 4 million credit facility in November 2024 to scale up manufacturing of its DISCOV-R POC following Medicare clearance, highlighting the commercial momentum behind next-generation portable devices.

Emerging markets and government-backed initiatives are opening new growth corridors that manufacturers cannot afford to overlook. China allocated USD 1.5 billion toward medical equipment in 2023 as part of broader healthcare reform, directly stimulating POC adoption across a country where over 100 million people suffer from COPD. India's Make in India push has attracted domestic producers like Oxymed, which launched its P2 POC in September 2024, serving patients across 50 cities with a device offering up to 10 hours of battery life. In Latin America, Mexico's Seguro Popular subsidies and Brazil's healthcare spending at 9.47% of GDP are making POCs more accessible, encouraging global players and regional distributors to deepen their presence.

Leading Companies Operating in the Global Portable Oxygen Concentrators Industry:

• Caire Inc. (NGK Spark Plug Co. Ltd)
• Chart Industries Inc.
• Drive Devilbiss Healthcare Limited (Drive International LLC)
• Inogen Inc.
• Invacare Corporation
• Koninklijke Philips N.V.
• Nidek Medical India Pvt Ltd
• O2 Concepts LLC
• Precision Medical Inc. (BioHorizons Inc.)
• Resmed Inc.
• Teijin Limited

Portable Oxygen Concentrators Market Report Segmentation:

By Technology:

• Continuous Flow
• Pulse Flow

Pulse flow represents the leading segment with 69.5% market share, offering synchronized oxygen delivery, low wastage, lightweight design, and strong suitability for active and ambulatory patients.

By Application:

• Chronic Obstructive Pulmonary Disease (COPD)

• Asthma
• Respiratory Distress Syndrome
• Sleep Apnea
• Others

COPD dominates with a 43.2% share, driven by its high global prevalence and the long-term supplemental oxygen needs of patients, particularly among aging populations.

By End User:

• Hospitals
• Ambulatory Surgery Centers
• Others

Ambulatory surgery centers hold the largest share, reflecting the growing trend toward outpatient care where POCs provide efficient pre- and post-operative respiratory support in space-constrained, high-turnover settings.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the global market with over 38.9% share, backed by a high prevalence of chronic respiratory conditions, strong Medicare reimbursement policies, and a well-established network of healthcare providers driving consistent POC adoption.

Recent News and Developments in Portable Oxygen Concentrators Market

• November 2024: Belluscura secured a USD 4 million credit facility with Sallyport Commercial Finance following Medicare clearance for its DISCOV-R portable oxygen concentrator, enabling the company to accelerate manufacturing and B2B market entry.
• November 2024: The Indian government launched a Rs 500 crore medical devices initiative targeting local production of oxygen concentrators to reduce import reliance and position India as a global medical devices hub, with the sector projected to reach USD 30 billion by 2030.
• October 2024: Inogen Inc. launched the Rove 4 Portable Oxygen Concentrator featuring a fourth flow setting delivering 840ml/min of oxygen, up to 5.75 hours of operation, and a design weighing under 3 pounds, advancing ambulatory oxygen therapy options for patients.
• September 2024: Oxymed launched the P2 Portable Oxygen Concentrator in India, weighing 1.98 kg and delivering 90-95% oxygen purity across five pulse flow settings, with up to 10 hours of battery life and service support available across 50 Indian cities.
• August 2024: O2 Concepts announced a strategic partnership with VGM and Associates, expanding its POC device portfolio and DNA fleet management platform across the VGM Respiratory member network, strengthening respiratory care delivery.
• June 2024: Inogen published a study in Pulmonary Therapy based on data from 244,000 patients, confirming that POCs improve survival rates and deliver superior cost-effectiveness compared to conventional long-term oxygen therapies.
• March 2024: Drive DeVilbiss Healthcare and Sanrai International unveiled the PulmO2 10L Oxygen Concentrator, designed for low-resource global settings with energy savings of up to 64% versus traditional models, supported by the UK government to expand access in underserved regions.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.